Bacterial challenges and evolving antibacterial drug strategy.
作者信息
Watt B, Collee J G
机构信息
Bacteriology Laboratory, City Hospital, Edinburgh, UK.
出版信息
Postgrad Med J. 1992 Jan;68(795):6-21. doi: 10.1136/pgmj.68.795.6.
Abstract
摘要
相似文献
1
Bacterial challenges and evolving antibacterial drug strategy.细菌挑战与不断演变的抗菌药物策略
Postgrad Med J. 1992 Jan;68(795):6-21. doi: 10.1136/pgmj.68.795.6.
2
[New antibacterial agents].[新型抗菌剂]
Duodecim. 2000;116(24):2803-5.
3
[Drug positioning of parenteral fluoroquinolones in management of infectious diseases. Discussion].
Jpn J Antibiot. 2002 Aug;55(4):345-60.
4
Metronidazole, clindamycin, and quinolones.
Obstet Gynecol Clin North Am. 1989 Jun;16(2):317-28.
5
[Chlamydia trachomatis].
Nihon Rinsho. 2003 Feb;61 Suppl 2:485-9.
6
Have we reached the point of no return? The hidden impact of antibacterial resistance in respiratory tract infection. Introduction.
Respir Med. 2001 Jun;95 Suppl A:S2-4; discussion S26-7. doi: 10.1016/s0954-6111(01)90021-6.
7
[Chlamydia (Chlamydophila) pneumoniae pneumonia].[肺炎衣原体肺炎]
Nihon Rinsho. 2003 Feb;61 Suppl 2:490-5.
8
[Comparative effectiveness of the strategies of etiotropic therapy of generalized chlamydia infections in young patients].
Urologiia. 2000 Sep-Oct(5):23-6.
9
Therapeutic monitoring of antimicrobials: a summary of the information presented at the UK NEQAS for antibiotic Assays meeting for participants, October 1993.抗菌药物的治疗监测：1993年10月英国抗生素检测室间质评会议上向参会者提供的信息总结
J Antimicrob Chemother. 1995 Jan;35(1):213-26. doi: 10.1093/jac/35.1.213.
10
Treatment of bacterial infections.细菌感染的治疗。
Semin Perinatol. 1985 Jan;9(1):38-46.
引用本文的文献
1
Ethiopia's Antibiotic Footprint: Employing the Newly Emerging Digital Concept to Estimate Annual Consumption for the Country.埃塞俄比亚的抗生素足迹：运用新兴数字概念估算该国的年度消费量。
Cureus. 2023 Mar 11;15(3):e36013. doi: 10.7759/cureus.36013. eCollection 2023 Mar.
2
In vitro antimicrobial activity of a new antibiotic, MDL 62,879 (GE2270 A).新型抗生素MDL 62,879（GE2270 A）的体外抗菌活性
Antimicrob Agents Chemother. 1993 Apr;37(4):741-5. doi: 10.1128/AAC.37.4.741.
本文引用的文献
1
Psittacosis in man - recent developments in the UK: a review.人类鹦鹉热——英国近期进展：综述
J R Soc Med. 1982 Apr;75(4):262-7. doi: 10.1177/014107688207500412.
2
Erythromycin uptake and accumulation by human polymorphonuclear leukocytes and efficacy of erythromycin in killing ingested Legionella pneumophila.红霉素被人多形核白细胞摄取和积累以及红霉素杀灭摄入的嗜肺军团菌的效力。
J Infect Dis. 1984 May;149(5):714-8. doi: 10.1093/infdis/149.5.714.
3
Mycoplasma pneumoniae respiratory disease symposium: summation and significance.肺炎支原体呼吸道疾病研讨会：总结与意义
Yale J Biol Med. 1983 Sep-Dec;56(5-6):523-7.
4
DNA gyrase and the supercoiling of DNA.DNA 回旋酶与 DNA 的超螺旋化
Science. 1980 Feb 29;207(4434):953-60. doi: 10.1126/science.6243420.
5
The in-vitro activity of ciprofloxacin compared with that of norfloxacin and nalidixic acid.环丙沙星与诺氟沙星和萘啶酸的体外活性比较。
J Antimicrob Chemother. 1984 Apr;13(4):325-31. doi: 10.1093/jac/13.4.325.
6
Hospital study of adult community-acquired pneumonia.成人社区获得性肺炎的医院研究。
Lancet. 1982 Jul 31;2(8292):255-8. doi: 10.1016/s0140-6736(82)90334-8.
7
Double-blind placebo controlled trial of erythromycin for treatment of Campylobacter enteritis.红霉素治疗空肠弯曲菌肠炎的双盲安慰剂对照试验。
Lancet. 1982 Jan 16;1(8264):131-2. doi: 10.1016/s0140-6736(82)90380-4.
8
The prevention of superinfection in multiple trauma patients.多发伤患者二重感染的预防
J Antimicrob Chemother. 1984 Sep;14 Suppl B:203-11. doi: 10.1093/jac/14.suppl_b.203.
9
Transposition of ampicillin resistance from RP4 to other replicons.氨苄青霉素抗性从RP4转座至其他复制子。
Mol Gen Genet. 1974;132(1):31-40. doi: 10.1007/BF00268228.
10
Uptake, accumulation, and egress of erythromycin by tissue culture cells of human origin.红霉素在人源组织培养细胞中的摄取、积累及排出。
Antimicrob Agents Chemother. 1985 Mar;27(3):314-9. doi: 10.1128/AAC.27.3.314.
Zotero 插件